Published in Int J Oncol on February 01, 2010
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer (2012) 1.05
Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. World J Gastroenterol (2011) 1.02
Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro Oncol (2010) 0.95
Metabolic characterization of triple negative breast cancer. BMC Cancer (2014) 0.94
Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy. NMR Biomed (2014) 0.90
¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. Br J Cancer (2010) 0.89
Molecular alterations in glioblastoma: potential targets for immunotherapy. Prog Mol Biol Transl Sci (2011) 0.86
Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information. Metabolites (2015) 0.83
Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation. MAGMA (2012) 0.79
Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels. J Magn Reson Imaging (2014) 0.79
Gene expression mapping of histone deacetylases and co-factors, and correlation with survival time and 1H-HRMAS metabolomic profile in human gliomas. Sci Rep (2015) 0.79
In vivo (1) H MRSI of glycine in brain tumors at 3T. Magn Reson Med (2015) 0.78
Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int J Cancer (2015) 0.77
Mapping of glycine distributions in gliomas. AJNR Am J Neuroradiol (2014) 0.76
Analysis of plasma free amino acid profiles in canine brain tumors. Biomed Rep (2016) 0.75
Discrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR Spectroscopy. PLoS One (2016) 0.75
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. PLoS One (2016) 0.75
Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol (2017) 0.75
Molecular imaging. Radiology (2001) 5.67
Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology (2008) 2.65
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med (2006) 2.04
ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed (2006) 1.67
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia (2007) 1.62
Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem (2002) 1.62
Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol (2000) 1.50
Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol (2004) 1.25
L-serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons. Proc Natl Acad Sci U S A (2000) 1.22
Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed (1997) 1.20
Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study. Magn Reson Med (2003) 1.17
A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med (2000) 1.17
Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: a 1H-MRS study. Magn Reson Med (2008) 1.15
Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed (2005) 1.11
Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry (1996) 1.09
High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med (1992) 1.08
Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans (2006) 1.08
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatry (2004) 1.02
Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol (2001) 1.01
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg (2003) 0.99
Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR Biomed (2008) 0.98
Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med (2007) 0.97
In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T. MAGMA (2008) 0.97
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA (2008) 0.95
Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol (2002) 0.95
In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med (2006) 0.94
Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery (1994) 0.93
Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation. Eur Radiol (2001) 0.92
Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia. Pediatr Res (2002) 0.87
Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA (1996) 0.86
In vivo 1H NMR measurement of glycine in rat brain at 9.4 T at short echo time. Magn Reson Med (2008) 0.84
Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine. Biochem Biophys Res Commun (1998) 0.83
Glycine therapy of schizophrenia. Biol Psychiatry (1988) 0.83
Analysis of the changes in the 1H NMR spectral pattern of perchloric acid extracts of C6 cells with growth. NMR Biomed (2006) 0.81
Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci U S A (2005) 3.37
Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron (2012) 2.84
Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60
A 24-year-old woman with intractable seizures: review of surgery for epilepsy. JAMA (2008) 2.55
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol (2004) 2.24
Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer (2005) 1.97
Neurosurgery certification in member societies of the WFNS: global overview. World Neurosurg (2011) 1.87
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res (2011) 1.69
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther (2003) 1.65
History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer (2002) 1.62
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 1.57
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res (2006) 1.54
Secondary structure, dynamics, and topology of a seven-helix receptor in native membranes, studied by solid-state NMR spectroscopy. Angew Chem Int Ed Engl (2007) 1.54
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol (2009) 1.51
Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer (2005) 1.50
Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer (2006) 1.49
Burn injury causes mitochondrial dysfunction in skeletal muscle. Proc Natl Acad Sci U S A (2005) 1.46
Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res (2006) 1.44
Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology (2006) 1.42
Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery. Neuroimage (2006) 1.41
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res (2004) 1.40
Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells (2009) 1.40
Immediate titanium mesh cranioplasty for treatment of postcraniotomy infections. World Neurosurg (2011) 1.39
Neurosurgery certification in member societies of the WFNS: Europe. World Neurosurg (2011) 1.39
Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res (2009) 1.38
Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog (2007) 1.38
Capturing intraoperative deformations: research experience at Brigham and Women's Hospital. Med Image Anal (2004) 1.35
Real-time motion and B0 corrected single voxel spectroscopy using volumetric navigators. Magn Reson Med (2011) 1.34
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2003) 1.28
SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer (2010) 1.26
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol (2008) 1.26
Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (2007) 1.20
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res (2007) 1.17
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2007) 1.17
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol (2007) 1.15
Image-guided neurosurgery at Brigham and Women's Hospital. IEEE Eng Med Biol Mag (2006) 1.14
Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol (2008) 1.13
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma. Cancer Res (2011) 1.13
Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models. Bone (2010) 1.12
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res (2005) 1.08
Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis. FASEB J (2005) 1.07
Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res (2004) 1.06
Connectivity alterations assessed by combining fMRI and MR-compatible hand robots in chronic stroke. Neuroimage (2009) 1.05
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Matrix solution fixation: histology-compatible tissue preparation for MALDI mass spectrometry imaging. Anal Chem (2007) 1.05
Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res (2010) 1.04
Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res (2009) 1.03
Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies: Asia. World Neurosurg (2011) 1.03
Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery (2008) 1.02
Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res (2008) 1.02
The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007. Neurosurgery (2008) 1.00
Structural characterization of Ca(2+)-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy. Biochemistry (2008) 1.00
Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy. J Magn Reson (2008) 0.99
Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol (2012) 0.98
Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev (2003) 0.97
Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med (2007) 0.97
Sociodemographic indicators and risk of brain tumours. Int J Epidemiol (2003) 0.97
A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery (2007) 0.97
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer (2011) 0.96
Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology (2002) 0.96
From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma. Neurosurg Focus (2013) 0.95
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol (2006) 0.93
Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. Radiology (2011) 0.92
Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol (2007) 0.92
Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Chem (2010) 0.91
Origins of intraoperative MRI. Neurosurg Clin N Am (2009) 0.91
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 0.90
Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med (2004) 0.90
Reduced rate of adenosine triphosphate synthesis by in vivo 31P nuclear magnetic resonance spectroscopy and downregulation of PGC-1beta in distal skeletal muscle following burn. Int J Mol Med (2008) 0.90
The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report. Neurosurgery (2008) 0.90
Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Microarray analysis suggests that burn injury results in mitochondrial dysfunction in human skeletal muscle. Int J Mol Med (2009) 0.89
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia (2012) 0.89
MR_CHIROD v.2: magnetic resonance compatible smart hand rehabilitation device for brain imaging. IEEE Trans Neural Syst Rehabil Eng (2008) 0.88
Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol (2007) 0.88
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J (2007) 0.88
Burn trauma in skeletal muscle results in oxidative stress as assessed by in vivo electron paramagnetic resonance. Mol Med Rep (2008) 0.88
Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol (2008) 0.87
Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia. Int J Mol Med (2010) 0.87
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin Cancer Res (2009) 0.86
Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage. Magn Reson Med (2013) 0.86
Real-time motion and B0 correction for localized adiabatic selective refocusing (LASER) MRSI using echo planar imaging volumetric navigators. NMR Biomed (2011) 0.86
Local and distant burn injury alter immuno-inflammatory gene expression in skeletal muscle. J Trauma (2006) 0.86
Compensation of geometric distortion effects on intraoperative magnetic resonance imaging for enhanced visualization in image-guided neurosurgery. Neurosurgery (2008) 0.85
A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin (2004) 0.85
Murine intramyocellular lipids quantified by NMR act as metabolic biomarkers in burn trauma. Int J Mol Med (2008) 0.85
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect (2005) 0.85
Statistical validation of brain tumor shape approximation via spherical harmonics for image-guided neurosurgery. Acad Radiol (2005) 0.85